| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 9.977 | 10.754 | 10.744 | 8.677 |
| Total Income - EUR | - | - | - | - | - | 0 | 9.977 | 10.754 | 10.744 | 8.677 |
| Total Expenses - EUR | - | - | - | - | - | 169 | 4.427 | 4.030 | 1.576 | 1.492 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -169 | 5.550 | 6.725 | 9.168 | 7.186 |
| Net Profit/Loss - EUR | - | - | - | - | - | -169 | 5.281 | 6.418 | 7.774 | 6.094 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ingrid Derma Line S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 507 | 776 | 613 | 170 |
| Current Assets | - | - | - | - | - | 79 | 7.722 | 6.987 | 9.254 | 6.714 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 6.935 | 6.701 | 0 |
| Cash | - | - | - | - | - | 79 | 7.722 | 52 | 2.554 | 6.714 |
| Shareholders Funds | - | - | - | - | - | -128 | 5.156 | 6.467 | 7.823 | 6.142 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 207 | 3.072 | 1.296 | 2.044 | 742 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ingrid Derma Line S.r.l.